Hanson & Doremus Investment Management Aditxt, Inc. Transaction History

Hanson & Doremus Investment Management

  • $627 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021
SELL
$2.2 - $3.2 $1,001 - $1,456
-455 Closed
0 $0
Q1 2021

May 03, 2021
BUY
$2.08 - $5.26 $946 - $2,393
455 New
455 $1,000

About Aditxt, Inc.

ADTX Quotes by TradingView
  • Ticker ADTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,161,130
  • Market Cap $749K
  • Description
  • Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...
More about ADTX
Track This Portfolio

Track Hanson & Doremus Investment Management Portfolio

Follow Hanson & Doremus Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email